JP2002507566A - 口内乾燥症を低減させるオキシブチニン徐放性組成物 - Google Patents
口内乾燥症を低減させるオキシブチニン徐放性組成物Info
- Publication number
- JP2002507566A JP2002507566A JP2000537542A JP2000537542A JP2002507566A JP 2002507566 A JP2002507566 A JP 2002507566A JP 2000537542 A JP2000537542 A JP 2000537542A JP 2000537542 A JP2000537542 A JP 2000537542A JP 2002507566 A JP2002507566 A JP 2002507566A
- Authority
- JP
- Japan
- Prior art keywords
- oxybutynin
- dosage form
- sustained release
- release dosage
- xerostomia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7942998P | 1998-03-26 | 1998-03-26 | |
| US60/079,429 | 1998-03-26 | ||
| PCT/US1999/006049 WO1999048494A1 (en) | 1998-03-26 | 1999-03-19 | Sustained-release composition of oxybutynin with reduced xerostomia effect |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002507566A true JP2002507566A (ja) | 2002-03-12 |
| JP2002507566A5 JP2002507566A5 (cg-RX-API-DMAC7.html) | 2005-06-02 |
Family
ID=22150487
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000537542A Pending JP2002507566A (ja) | 1998-03-26 | 1999-03-19 | 口内乾燥症を低減させるオキシブチニン徐放性組成物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20010009995A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2002507566A (cg-RX-API-DMAC7.html) |
| AR (1) | AR018321A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU3103799A (cg-RX-API-DMAC7.html) |
| WO (1) | WO1999048494A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU6403600A (en) * | 1999-06-10 | 2001-01-02 | Sepracor, Inc. | Methods and compositions for treating urinary frequency and urgency using optically pure (s)-oxybutynin |
| US7179483B2 (en) | 2000-04-26 | 2007-02-20 | Watson Pharmaceuticals, Inc. | Compositions and methods for transdermal oxybutynin therapy |
| AU5378201A (en) | 2000-04-26 | 2001-11-07 | Watson Pharmaceuticals Inc | Minimizing adverse experience associated with oxybutynin therapy |
| US7029694B2 (en) | 2000-04-26 | 2006-04-18 | Watson Laboratories, Inc. | Compositions and methods for transdermal oxybutynin therapy |
| AR053986A1 (es) | 2004-12-03 | 2007-05-30 | Osmotica Pharmaceutical Argent | Dispositivo osmotico que contiene amantadina y una sal osmotica |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2799241A (en) * | 1949-01-21 | 1957-07-16 | Wisconsin Alumni Res Found | Means for applying coatings to tablets or the like |
| US3845770A (en) * | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
| US3916899A (en) * | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
| GB1478759A (en) * | 1974-11-18 | 1977-07-06 | Alza Corp | Process for forming outlet passageways in pills using a laser |
| US4008719A (en) * | 1976-02-02 | 1977-02-22 | Alza Corporation | Osmotic system having laminar arrangement for programming delivery of active agent |
| US4063064A (en) * | 1976-02-23 | 1977-12-13 | Coherent Radiation | Apparatus for tracking moving workpiece by a laser beam |
| US4200098A (en) * | 1978-10-23 | 1980-04-29 | Alza Corporation | Osmotic system with distribution zone for dispensing beneficial agent |
| US4285987A (en) * | 1978-10-23 | 1981-08-25 | Alza Corporation | Process for manufacturing device with dispersion zone |
| US4327725A (en) * | 1980-11-25 | 1982-05-04 | Alza Corporation | Osmotic device with hydrogel driving member |
| US4612008A (en) * | 1983-05-11 | 1986-09-16 | Alza Corporation | Osmotic device with dual thermodynamic activity |
| US4783337A (en) * | 1983-05-11 | 1988-11-08 | Alza Corporation | Osmotic system comprising plurality of members for dispensing drug |
| US4863456A (en) * | 1986-04-30 | 1989-09-05 | Alza Corporation | Dosage form with improved delivery capability |
| US4816263A (en) * | 1987-10-02 | 1989-03-28 | Alza Corporation | Dosage form for treating cardiovascular diseases comprising isradipine |
| US4902514A (en) * | 1988-07-21 | 1990-02-20 | Alza Corporation | Dosage form for administering nilvadipine for treating cardiovascular symptoms |
| US5178868A (en) * | 1988-10-26 | 1993-01-12 | Kabi Pharmacia Aktiebolaq | Dosage form |
| US5202128A (en) * | 1989-01-06 | 1993-04-13 | F. H. Faulding & Co. Limited | Sustained release pharmaceutical composition |
| SE8904296D0 (sv) * | 1989-12-21 | 1989-12-21 | Pharmacia Ab | Transdermal system |
| US5480651A (en) * | 1992-03-16 | 1996-01-02 | Regents Of The University Of California | Composition and method for treating nicotine craving in smoking cessation |
| JP2665858B2 (ja) * | 1992-05-30 | 1997-10-22 | 日本ヘキスト・マリオン・ルセル株式会社 | 持効性塩酸オキシブチニン製剤 |
| US5399359A (en) * | 1994-03-04 | 1995-03-21 | Edward Mendell Co., Inc. | Controlled release oxybutynin formulations |
| AU7994694A (en) * | 1994-10-21 | 1996-05-15 | Leiras Oy | Controlled release oral delivery system containing oxybutynin |
| US5965161A (en) * | 1994-11-04 | 1999-10-12 | Euro-Celtique, S.A. | Extruded multi-particulates |
| US5532278A (en) * | 1995-01-31 | 1996-07-02 | Sepracor, Inc. | Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin |
| US6262115B1 (en) * | 1995-05-22 | 2001-07-17 | Alza Coporation | Method for the management of incontinence |
| US5674895A (en) * | 1995-05-22 | 1997-10-07 | Alza Corporation | Dosage form comprising oxybutynin |
| US5912268A (en) * | 1995-05-22 | 1999-06-15 | Alza Corporation | Dosage form and method for treating incontinence |
| IL126232A (en) * | 1996-04-11 | 2001-05-20 | Basf Ag | Synergistic fungicidal mixtures |
| AU6876498A (en) * | 1997-04-03 | 1998-10-22 | Point Biomedical Corporation | Intravesical drug delivery system |
| AU5378201A (en) * | 2000-04-26 | 2001-11-07 | Watson Pharmaceuticals Inc | Minimizing adverse experience associated with oxybutynin therapy |
| US6368628B1 (en) * | 2000-05-26 | 2002-04-09 | Pharma Pass Llc | Sustained release pharmaceutical composition free of food effect |
| US20030185882A1 (en) * | 2001-11-06 | 2003-10-02 | Vergez Juan A. | Pharmaceutical compositions containing oxybutynin |
-
1999
- 1999-03-05 AR ARP990100963A patent/AR018321A1/es unknown
- 1999-03-19 WO PCT/US1999/006049 patent/WO1999048494A1/en not_active Ceased
- 1999-03-19 AU AU31037/99A patent/AU3103799A/en not_active Abandoned
- 1999-03-19 JP JP2000537542A patent/JP2002507566A/ja active Pending
-
2001
- 2001-03-07 US US09/801,443 patent/US20010009995A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999048494A1 (en) | 1999-09-30 |
| AR018321A1 (es) | 2001-11-14 |
| US20010009995A1 (en) | 2001-07-26 |
| AU3103799A (en) | 1999-10-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100404954B1 (ko) | 옥시부티닌을포함하는약제형 | |
| US5912268A (en) | Dosage form and method for treating incontinence | |
| EP0946151B1 (en) | Ascending-dose dosage form | |
| AU685297B2 (en) | Tacrine pharmaceutical compositions | |
| DE69524214T3 (de) | Azithromycin enthaltende arzneiverabreichungsformen mit gesteuerter wirkstoffabgabe | |
| DE69720055T2 (de) | Verabreichungsform zur abgabe von steigenden wirkstoffdosen | |
| EP1059917B1 (en) | Pharmaceutical preparation for use in anti-asthma therapy | |
| JPH09512550A (ja) | 抗癲癇薬の効果的な投与形態 | |
| CH671696A5 (cg-RX-API-DMAC7.html) | ||
| EP2335691A1 (de) | Vardenafil Formulierungen mit kontrollierter Wirkstofffreisetzung | |
| DE112011101605T5 (de) | Pharmazeutische Zusammensetzung umfassend Hydromorphon und Naloxon | |
| EP1216031A2 (en) | Dosage forms and methods for providing effective reboxetine therapy with once-a-day dosing | |
| US6124355A (en) | Oxybutynin therapy | |
| WO2006108519A1 (de) | Kombination zur therapie bei benigner prostatahyperplasie | |
| DE3829941A1 (de) | Abgabevorrichtung zur verabreichung von diltiazem | |
| EP1782798A2 (en) | Ascending-dose dosage form | |
| US20010009995A1 (en) | Oxybutynin therapy | |
| US10610505B2 (en) | Controlled release dosage form | |
| US20020142033A1 (en) | Method for treating incontinence | |
| WO2000019997A1 (en) | Controlled release dosage from comprising oxybutynin | |
| HK1103653A (en) | Ascending-dose dosage form | |
| HK1021620B (en) | Ascending-dose dosage form | |
| HK1033278B (en) | Pharmaceutical preparation for use in anti-asthma therapy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20071009 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20080109 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20080117 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20080408 |